ePrivacy and GPDR Cookie Consent by TermsFeed Generator

DOXIPROCT PLUS

40MG/G+20MG/G+0,25MG/G RCT UNG 20G

SÚKL code 0042179
Name of the product DOXIPROCT PLUS
_MA_MEDICATION_DETAIL_INFO_MED_NAME i DOXIPROCT PLUS
Supplement 40MG/G+20MG/G+0,25MG/G RCT UNG 20G
Strenght 40MG/G+20MG/G+0,25MG/G
Pharmaceutical form Rectal ointment
Package 20G
Route Rectal use
Language of the pack Czech
Wrap type Applicator
Legal status na lékařský předpis
Active substance LIDOCAINE HYDROCHLORIDE MONOHYDRATE (LIDOCAINI HYDROCHLORIDUM MONOHYDRICUM)
DEXAMETHASONE ACETATE (DEXAMETHASONI ACETAS)
CALCIUM DOBESILATE MONOHYDRATE (CALCII DOBESILAS MONOHYDRICUS)
ATC group C05AA09
ATC group name DEXAMETHASON
Doping Glukokortikosteroidy (zakázané pouze při soutěži). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 23/ 244/75-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 11. 2022
MA Holder OM Pharma S.A., Amadora - Lisboa
MA Holder country PORTUGALSKO
Actual MA holder OMEDICAMED Unipessoal, Lisabon
Actual MA holder country PORTUGALSKO

Back to list